ProCE Banner Activity

Nursing Care for Patients With NSCLC in an Era of Personalized Medicine

Multimedia
In this archived Webcast from the 2017 CCO NSCLC nurses chapter meeting series, Gail Kwarciany, MSN, RN-BC, OCN, AOCNS, provides expert perspective on optimal nursing strategies for patients with non-small-cell lung cancer.

Released: November 20, 2017

Expiration: November 19, 2018

No longer available for credit.

Share

Faculty

Diane Cope

Diane Cope, PhD, ARNP-BC, AOCNP

Oncology Nurse Practitioner
Chair,
Clinical Directions Team
Florida Cancer Specialists and Research Institute
Fort Myers, Florida

Anne Zobec

Anne Zobec, RN, MS, AOCNP

Oncology Nurse Practitioner
Rocky Mountain Cancer Center
Colorado Springs, Colorado

Gail Kwarciany

Gail Kwarciany, MSN, RN-BC, OCN, AOCNS

Oncology Clinical Nurse Specialist
The University of Texas Medical Branch
Galveston, Texas

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

This activity is supported by educational grants from

Celgene

Novartis Pharmaceuticals Corporation

Learning Objectives

  • Explain the rationale for and the importance of biopsy procedures to patients with non-small-cell lung cancer
  • Communicate effectively with patients with advanced or metastatic non-small-cell lung cancer so that they will understand their individualized treatment plan
  • Gain insight on individualized choice of chemotherapy based on histology as well as patient age/fitness, comorbidities, and preference
  • Manage treatment-related and disease-related adverse events in patients with non-small-cell lung cancer

Program Director Disclosure

Program Director

Diane Cope, PhD, ARNP-BC, AOCNP

Oncology Nurse Practitioner
Chair,
Clinical Directions Team
Florida Cancer Specialists and Research Institute
Fort Myers, Florida

Diane Cope, PhD, ARNP-BC, AOCNP, has no real or apparent conflicts of interest to report.

Anne Zobec, RN, MS, AOCNP

Oncology Nurse Practitioner
Rocky Mountain Cancer Center
Colorado Springs, Colorado

Anne Zobec, RN, MS, AOCNP, has disclosed that she has received fees for non-CME/CE services from Amgen, Astellas, Clovis, Exelixis, and Genentech.

Faculty Disclosure

Primary Author

Gail Kwarciany, MSN, RN-BC, OCN, AOCNS

Oncology Clinical Nurse Specialist
The University of Texas Medical Branch
Galveston, Texas

Gail Kwarciany, MSN, RN-BC, OCN, AOCNS, has no real or apparent conflicts of interest to report.

Staff Disclosure

Staff

Rachael M. Andrie, PhD

Clinical Editor

Rachael M. Andrie, PhD, has no real or apparent conflicts of interest to report.

Terrence Fagan,

Associate Scientific Director

Terrence Fagan has no real or apparent conflicts of interest to report.

Gordon Kelley,

Clinical Editor
Clinical Care Options, LLC

Gordon Kelley has no real or apparent conflicts of interest to report.

Kevin Obholz, PhD

Editorial Director, Hematology/Oncology

Kevin Obholz, PhD, has no real or apparent conflicts of interest to report.